| Dr Virginia H Price, MD | |
|
705 Dallas Hwy Ste 101, Villa Rica, GA 30180-1243 | |
| (770) 459-4411 | |
| (770) 459-1896 |
| Full Name | Dr Virginia H Price |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 47 Years |
| Location | 705 Dallas Hwy Ste 101, Villa Rica, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083688873 | NPI | - | NPPES |
| 00207578A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 019897 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Home Health Care, An Amedisys Company | Douglasville, GA | Home health agency |
| Tanner Medical Center Villa Rica | Villa rica, GA | Hospital |
| Tanner Medical Center - Carrollton | Carrollton, GA | Hospital |
| Wellstar Douglas Hospital | Douglasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanner Medical Group | 2769536143 | 98 |
News Archive
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific, two UN agencies said today. ''So far, food contamination incidents and food-borne disease outbreaks in the region have been relatively isolated, but the potential danger is just round the corner.
Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced interim clinical results for the company's two lead product candidates, an intravenous recombinant porcine FVIII (OBI-1) in the treatment of serious bleeds in acquired hemophilia A (AHA) and an intravenous recombinant FIX (IB1001) for the treatment and prevention of bleeding in children less than 12 years of age with hemophilia B.
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells.
› Verified 8 days ago
| Entity Name | Tanner Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396979787 PECOS PAC ID: 2769536143 Enrollment ID: O20090819000657 |
News Archive
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific, two UN agencies said today. ''So far, food contamination incidents and food-borne disease outbreaks in the region have been relatively isolated, but the potential danger is just round the corner.
Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced interim clinical results for the company's two lead product candidates, an intravenous recombinant porcine FVIII (OBI-1) in the treatment of serious bleeds in acquired hemophilia A (AHA) and an intravenous recombinant FIX (IB1001) for the treatment and prevention of bleeding in children less than 12 years of age with hemophilia B.
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Virginia H Price, MD 705 Dallas Hwy Ste 101, Villa Rica, GA 30180-1243 Ph: (770) 459-4411 | Dr Virginia H Price, MD 705 Dallas Hwy Ste 101, Villa Rica, GA 30180-1243 Ph: (770) 459-4411 |
News Archive
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
Foodborne diseases pose a serious threat to densely populated areas of Asia and the Pacific, two UN agencies said today. ''So far, food contamination incidents and food-borne disease outbreaks in the region have been relatively isolated, but the potential danger is just round the corner.
Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart.
Inspiration Biopharmaceuticals, Inc. (Inspiration) announced interim clinical results for the company's two lead product candidates, an intravenous recombinant porcine FVIII (OBI-1) in the treatment of serious bleeds in acquired hemophilia A (AHA) and an intravenous recombinant FIX (IB1001) for the treatment and prevention of bleeding in children less than 12 years of age with hemophilia B.
This month, Molecular Pharmaceutics reported promising findings from the Nemours Center for Childhood Cancer Research and the Materials Science and Engineering Department at the University of Delaware, about the potential for nanotechnology to deliver chemotherapeutic agents in a way that attacks cancer cells without harming healthy cells.
› Verified 8 days ago
James Larry Boss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 517 Leslie Dr, Villa Rica, GA 30180 Phone: 770-459-5179 | |
Dr. Kenneth L Boss, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 705 Dallas Hwy, Suite 101, Villa Rica, GA 30180 Phone: 770-456-4411 Fax: 770-812-3582 | |
Lori A Hudson, RN-FNPC Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 503 Main St, Villa Rica, GA 30180 Phone: 770-462-1170 Fax: 770-462-1174 | |
Dr. Henry Charles Guthery Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 809 W Bankhead Hwy Ste D, Villa Rica, GA 30180 Phone: 678-615-9519 | |
Mrs. Chandrika Garg, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Quartz Dr, Suite 101, Villa Rica, GA 30180 Phone: 770-949-7500 Fax: 770-942-8800 | |
Dr. India C. Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Permian Way, Suite A, Villa Rica, GA 30180 Phone: 678-840-4034 Fax: 678-840-4035 |